Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment

Evaluation of Liver Function Test to Identify Hepatotoxcicity Among Acute Leukemia Patients Who Are Receiving Chemotherapy Induction

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06383325

Enrollment

Registered

2024-04-25

Start date

2024-05-01

Completion date

2025-08-01

Last updated

2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Toxicity, Chemically-Induced

Brief summary

Detection of hepatotoxcicity in acute leukemia and study the outcome of acute leukemia patients that suffer from hepatic toxiciyt

Detailed description

Chemotherapy induction associated with hepatotoxicity during the induction has never been studied the study aimed to determine whether chemotherapy induction is associated with livertoxicity or not

Interventions

COMBINATION_PRODUCTChemotherapy

Detection of hepatotoxicity in acute leukemia patients during chemotherapy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* patients newly diagnosed with acute leukemia who are going to start chemotherapy treatment

Exclusion criteria

* patients previously diagnosed Acute leukemia and started treatment or in post treatment follow up

Design outcomes

Primary

Measure	Time frame	Description
Detection of hepatotoxcicity in acute leukemia during chemotherapy treatment	3 months	Evaluation of liver function test to identfy hepatotoxicity during chemotherapy treatment

Contacts

Primary ContactNada mohamed hamada Hamada wahba

Nm3390103@gmail.com01140476425

Backup ContactEnas Ahmed Reda alkareemy, Proffesor

alkareemy@aun.edu.eg01000004303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026